» Articles » PMID: 18583537

MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries

Abstract

We used massively parallel pyrosequencing to discover and characterize microRNAs (miRNAs) expressed in human embryonic stem cells (hESC). Sequencing of small RNA cDNA libraries derived from undifferentiated hESC and from isogenic differentiating cultures yielded a total of 425,505 high-quality sequence reads. A custom data analysis pipeline delineated expression profiles for 191 previously annotated miRNAs, 13 novel miRNAs, and 56 candidate miRNAs. Further characterization of a subset of the novel miRNAs in Dicer-knockdown hESC demonstrated Dicer-dependent expression, providing additional validation of our results. A set of 14 miRNAs (9 known and 5 novel) was noted to be expressed in undifferentiated hESC and then strongly downregulated with differentiation. Functional annotation analysis of predicted targets of these miRNAs and comparison with a null model using non-hESC-expressed miRNAs identified statistically enriched functional categories, including chromatin remodeling and lineage-specific differentiation annotations. Finally, integration of our data with genome-wide chromatin immunoprecipitation data on OCT4, SOX2, and NANOG binding sites implicates these transcription factors in the regulation of nine of the novel/candidate miRNAs identified here. Comparison of our results with those of recent deep sequencing studies in mouse and human ESC shows that most of the novel/candidate miRNAs found here were not identified in the other studies. The data indicate that hESC express a larger complement of miRNAs than previously appreciated, and they provide a resource for additional studies of miRNA regulation of hESC physiology. Disclosure of potential conflicts of interest is found at the end of this article.

Citing Articles

The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.

Ye J, Boileau R, Parchem R, Judson-Torres R, Blelloch R Stem Cells. 2025; 43(2).

PMID: 40037390 PMC: 11879289. DOI: 10.1093/stmcls/sxae080.


Molecular mechanism and therapeutic strategies for embryonal tumors with multilayered rosettes in children (Review).

Lv W, Gao J, Guo X Mol Clin Oncol. 2025; 22(3):30.

PMID: 39926370 PMC: 11803348. DOI: 10.3892/mco.2025.2825.


The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells.

Ye J, Boileau R, Parchem R, Judson-Torres R, Blelloch R bioRxiv. 2024; .

PMID: 39282363 PMC: 11398367. DOI: 10.1101/2024.09.02.610895.


Urinary miRNAs: Technical Updates.

Raveendran S, Al Massih A, Al Hashmi M, Saeed A, Al-Azwani I, Mathew R Microrna. 2024; 13(2):110-123.

PMID: 38778602 DOI: 10.2174/0122115366305985240502094814.


Identification of RNA-based cell-type markers for stem-cell manufacturing systems with a statistical scoring function.

Shi Y, Yang W, Lin H, Han L, Cai A, Saraf R Gene Rep. 2024; 34.

PMID: 38351912 PMC: 10861185. DOI: 10.1016/j.genrep.2023.101869.


References
1.
Aravin A, Tuschl T . Identification and characterization of small RNAs involved in RNA silencing. FEBS Lett. 2005; 579(26):5830-40. DOI: 10.1016/j.febslet.2005.08.009. View

2.
Grimson A, Farh K, Johnston W, Garrett-Engele P, Lim L, Bartel D . MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007; 27(1):91-105. PMC: 3800283. DOI: 10.1016/j.molcel.2007.06.017. View

3.
Boyer L, Lee T, Cole M, Johnstone S, Levine S, Zucker J . Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122(6):947-56. PMC: 3006442. DOI: 10.1016/j.cell.2005.08.020. View

4.
Ruby J, Jan C, Player C, Axtell M, Lee W, Nusbaum C . Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell. 2006; 127(6):1193-207. DOI: 10.1016/j.cell.2006.10.040. View

5.
Mimeault M, Hauke R, Batra S . Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 2007; 82(3):252-64. DOI: 10.1038/sj.clpt.6100301. View